About Exocell
Exocell is a Healthcare company based in Philadelphia (United States) founded in 1997. It operates as a diagnostic products for Diabetes and Cardiovascular disease. Its focus areas include Diversified Diagnostics.
Company details
Exocell develops, manufactures and markets a wide range of products and services related to management of diabetes and its complications. The companys product portfolio includes a range of diagnostic assay kits for diabetes and associated kidney and vascular diseases. The clinical diagnostics segment includes products to measure microalbuminuria, urinary creatinine, glycated albumin, glycated LDL, Hemoglobin A1c reference standard. It offers ELISA kits to measure human apolipoprotein B in plasma, type IV collagen, fibronectin in human plasma, urinary nephrin, podocalyxin in human tissueurine, BIG-H3 in human urine, Troponin I in human plasmaserum, TNF-α soluble receptor 2 in human urineplasmaserum.In addition, the company offers highly specific monoclonal antibodies (MAb) and well purified proteins.
- Headquarters Philadelphia, United States
- SectorsHealthcare
- Website exocell.com
- Latest Funding Round$500K (USD), Grant
Aug 1999
- Investors
Funding Insights of Exocell
- Total Rounds 1
- Last Round Grant β $500,000
- First Round $500,000
(Aug 1999)
- Investors Count 1
All 1 funding rounds of Exocell with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 1999 | $500,000 | Grant | β | β |
1 investors in total: 1 institutional.
Investors in Exocell
Exocell has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include National Institute of Diabetes and Digestive and Kidney Diseases.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Research and health information on diabetes and kidney diseases are provided by NIDDK. | 1950 | niddk.nih.gov | United States |
Investor details for Exocell
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Exocell
2 dated milestones of Exocell across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Exocell is founded.
- Funding First funding round of $500K.
Web traffic of Exocell
Websites that share an audience with Exocell (exocell.com).
Websites whose visitors overlap most with Exocell. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| prospecbio.com | 100% | 53.2K | #651,600 | View details | |
medicago.se | medicago.se | 100% | – | – | β |
| abnova.com | 100% | 30.7K | #957,320 | View details | |
celltechnology.com | celltechnology.com | 100% | – | – | β |
| usbio.net | 100% | 50K | #662,701 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 11 similar websites and full traffic analytics for Exocell
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 11 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Diagnostics & Lab Tech
10 companies that operate in the same segment as Exocell (Diagnostics & Lab Tech), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceuticals and diagnostics kits are developed for various diseases. | 1896 | Basel, Basel-stadt, Switzerland | – | USD 77.61 B | 103,250 | |
At-home health tests for biomarkers, nutrition, and hormone analysis. | 2014 | Austin, Texas, United States | USD 330 M | – | 336 | |
Point-of-care and laboratory blood analyzers are developed by EKF. | 1990 | Penarth, Wales, United Kingdom | USD 178.63 K | USD 69.43 M | 303 | |
Blood testing services are offered using finger-prick microsamples. | 2017 | Austin, Texas, United States | USD 37.7 M | – | – | |
Manufactures clinical diagnostic test kits | 1971 | Irvine, California, United States | – | USD 4.45 M | 54 | |
Biomarker-based diagnostic solutions for cancer and cardiovascular diseases are developed. | 2002 | Hennigsdorf, Brandenburg, Germany | USD 36.14 M | – | – | |
Diagnostic instrumentation and assays | 1987 | Puteaux, Hauts-de-seine, France | – | – | – | |
Manufacturer of Laboratory equipment | 1955 | Norwood, Massachusetts, United States | – | – | – | |
Cloud based diagnostics platform for point of care diagnosing | 2014 | Waltham, Massachusetts, United States | USD 703.91 M | USD 115.02 K | 9 | |
Diagnostics technology for infectious diseases and health monitoring is provided. | 2012 | Hong Kong, China | USD 34 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Exocell
Exocell was founded in 1997 and raised its 1st funding round 2 years after it was founded.
Exocell is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Exocell develops, manufactures and markets a wide range of products and services related to management of diabetes and its complications. The companys product portfolio includes a range of diagnostic assay kits for diabetes and associated kidney and vascular diseases. The clinical diagnostics segment includes products to measure microalbuminuria, urinary creatinine, glycated albumin, glycated LDL, Hemoglobin A1c reference standard. It offers ELISA kits to measure human apolipoprotein B in plasma, type IV collagen, fibronectin in human plasma, urinary nephrin, podocalyxin in human tissueurine, BIG-H3 in human urine, Troponin I in human plasmaserum, TNF-Ξ± soluble receptor 2 in human urineplasmaserum.In addition, the company offers highly specific monoclonal antibodies (MAb) and well purified proteins.
Exocell has 1 investor. Key investors include National Institute of Diabetes and Digestive and Kidney Diseases.